Skip to content
10-Q

Quarterly Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-21-002392

← back to feed
Filed
Sep 27, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jun 30, 2021 100M sh
Operating Cash Flow Q2 2021 · Jun 30, 2021 $0
Operating Cash Flow Q2 2021 · Jun 30, 2020 $1
Cash And Equivalents Q2 2021 · Jun 30, 2021 $1.35K
Cash And Equivalents Q2 2021 · Dec 31, 2020 $1.35K
Cash And Equivalents Q2 2021 · Jun 30, 2020 $1.35K
Cash And Equivalents Q2 2021 · Dec 31, 2019 $1.35K
Stockholders Equity Q2 2021 · Jun 30, 2021 −$340.68K
Stockholders Equity Q2 2021 · Mar 31, 2021 −$330.73K
Stockholders Equity Q2 2021 · Dec 31, 2020 −$319.78K
Stockholders Equity Q2 2021 · Jun 30, 2020 −$290.01K
Stockholders Equity Q2 2021 · Mar 31, 2020 −$279.99K
Stockholders Equity Q2 2021 · Dec 31, 2019 −$268.54K
Current Liabilities Q2 2021 · Jun 30, 2021 $342.03K
Current Liabilities Q2 2021 · Dec 31, 2020 $321.13K
Total Liabilities Q2 2021 · Jun 30, 2021 $342.03K
Total Liabilities Q2 2021 · Dec 31, 2020 $321.13K
Current Assets Q2 2021 · Jun 30, 2021 $1.35K
Current Assets Q2 2021 · Dec 31, 2020 $1.35K
Total Assets Q2 2021 · Jun 30, 2021 $1.35K
Total Assets Q2 2021 · Dec 31, 2020 $1.35K
Sga Expense Q2 2021 · Jun 30, 2021 $9.95K
Sga Expense Q2 2021 · Jun 30, 2021 $20.9K
Sga Expense Q2 2021 · Jun 30, 2020 $10.02K
Sga Expense Q2 2021 · Jun 30, 2020 $21.47K
Net Income Q2 2021 · Jun 30, 2021 −$9.95K
Net Income Q2 2021 · Jun 30, 2021 −$20.9K
Net Income Q2 2021 · Mar 31, 2021 −$10.95K
Net Income Q2 2021 · Jun 30, 2020 −$10.02K
Net Income Q2 2021 · Jun 30, 2020 −$21.47K
Net Income Q2 2021 · Mar 31, 2020 −$11.45K
Operating Income Q2 2021 · Jun 30, 2021 −$9.95K
Operating Income Q2 2021 · Jun 30, 2021 −$20.9K
Operating Income Q2 2021 · Jun 30, 2020 −$10.02K
Operating Income Q2 2021 · Jun 30, 2020 −$21.47K
Revenue Q2 2021 · Jun 30, 2021 $0
Revenue Q2 2021 · Jun 30, 2021 $0
Revenue Q2 2021 · Jun 30, 2020 $0
Revenue Q2 2021 · Jun 30, 2020 $0